J. Safra Asset Management’s Soleno Therapeutics SLNO Stock Holding History

J. Safra Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-174	Closed	-$5.83K	–	679
2026 Q1	$5.83K	Buy	174 +122	+235%	+$4.78K	﹤0.01%	441
2025 Q4	$2.41K	Buy	52 +45	+643%	+$2.47K	﹤0.01%	533
2025 Q3	$473	Hold	7	–	–	﹤0.01%	462
2025 Q2	$586	Hold	7	–	–	﹤0.01%	362
2025 Q1	$500	Buy	+7	New	+$341	﹤0.01%	339

J. Safra Asset Management's SLNO Position: Q2 2026 in Review

J. Safra Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 174 shares — an estimated $5.83K sold.

J. Safra Asset Management first reported a position in SLNO in Q1 2025 and held it in 5 quarters. The position peaked at $5.83K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

J. Safra Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
J. Safra Asset Management sold 174 Soleno Therapeutics shares in Q2 2026, an estimated $5.83K.
J. Safra Asset Management first reported a position in Soleno Therapeutics in Q1 2025 and held it in 5 quarters.
J. Safra Asset Management's Soleno Therapeutics position peaked at $5.83K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.